Covid symptoms timeline delta9/20/2023 ![]() ![]() Like the original strain, the Delta variant can affect many of the body’s organs including the lungs, heart and kidneys.Ĭomplications include blood clots, which at their most severe can result in strokes or heart attacks.Īround 10-30% of people with COVID-19 will experience prolonged symptoms, known as long COVID, which can last for months and cause significant impairment, including in people who were previously well.Įven previously well people can get long COVID. With faster replication and higher viral loads it is easy to see why Delta is challenging contact tracers and spreading so rapidly. For Delta, the viral load is up to roughly 1,200 times higher than the original strain. But there is often a gap between when a person becomes infectious to others to when they show symptoms.Īs the virus replicates, the viral load increases. The time from virus exposure to symptoms is called the incubation period. People with COVID-19 appear to be most infectious two days before to three days after symptoms start, though it’s unclear whether this differs with Delta. Although often there are no symptoms yet, the person has become infectious. So once the official booster rollout begins, consider rolling up your sleeves and getting a fresh jab to better protect yourself from EG.5.The virus then continues to replicate. There’s not an Eris-specific vaccine, but experts are optimistic that the forthcoming COVID-19 booster to target XBB.1.5 ( coming this Fall) will offer some level of protection against EG.5 since the two subvariants are similar in structure. This gives the new strain an edge over other recent former variations of the virus, making it potentially “easier to catch and transmit,” says Teitelbaum. Translation: If you get sick with Eris, you may not develop immunity that would prevent you from getting it again. What’s a bit more worrisome is that EG.5 has a spike protein mutation that allowed it to evade neutralizing antibodies in a lab setting, says the JAMA report. It’s a little too soon to know for sure, but early reports suggest that it may be more transmissible than previous subvariants, according to Yale Medicine experts. Still, like with previous COVID-19 subvariants, there are certain populations who should continue to be especially vigilant, such as individuals age 65 and older and people with underlying medical conditions that make them susceptible. ![]() And it’s definitely still an unknown how likely EG.5 is to result in long covid cases. Though there has been an increase in cases and hospitalizations, there’s no way of knowing whether it’s due to disease severity or transmissibility, says a recent JAMA report. “So far, the evidence suggests that Eris is similar in severity to other variants,” Teitelbaum explains. Shortness of breath, or difficulty breathing.“It predominantly affects the upper airway.”Īccording to the CDC, these are potential COVID-19 symptoms to watch out for: The symptoms of Eris “are similar to other strains of Covid,” Jacob Teitelbaum, MD, a board-certified internist of integrative medicine and author of From Fatigued to Fantastic, tells Good Housekeeping. And with COVID-19 testing rates and reporting no longer as closely tracked like they were during the height of the pandemic, it’s especially important to take steps to protect yourself from getting sick whenever a new variant of concern begins to swirl. This means the SARS CoV-2 virus continues to evolve, and Eris is just the latest mutation to keep an eye on. “Kraken”) subvariant that circulated earlier this year.ĮG.5 is a descendant of Omicron, just like XBB.1.5 was. So what should we expect from Eris as far as virality, symptoms and long-term effects? We're breaking all that down, plus how it compares to the last headline-making XBB.1.5 (a.k.a. There’s a new COVID-19 subvariant to watch (and protect yourself from): The new variant EG.5 -dubbed “Eris”-is now the dominant strain globally, with there being a noticeable spike in infections over the past four weeks, says the World Health Organization.Ībout 20.6% of new COVID-19 cases are thought to be caused by EG.5, according to data from the Centers for Disease Control and Prevention (CDC), a significant jump from 7.5% during the first week of July. Antiviral medications are still proving to be effective in shortening the length and severity of COVID-19, including subvariants like Eris.An updated booster shot, available in Fall 2023, may help protect people from Eris.The symptoms of Eris are similar to previous strains of the virus, but Eris may be able to more easily elude antibodies that people have developed from previous infection or vaccines.
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |